Friday 6 November 2026 Export LUNG’s income statement to Excel — free account

Pulmonx Corporation

LUNG Healthcare Medical Devices

Pulmonx Corporation’s revenue for fiscal 2025 (year ended December 2025) was $90.5 million, up 8.01% from fiscal 2024.

Revenue: +6.20%
EPS: +42.8%
Free cash flow: +61.3%
Total debt: +1.57%

Quarter to September 2026, against a year earlier

Revenue growth 5 yrs

2.56 0.00 0.00%

Follow LUNG

Alert me

Market cap: $111.5M
P/E: 0.0×
Fwd P/E: −3.1×
Dividend yield: —
F-score: 3/9
Altman Z: −4.84
Beneish M: −3.38
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	3	3	3	4
ROE Full definition →		(77.19%)	(86.22%)	(88.87%)	(90.31%)
ROA Full definition →		(36.97%)	(39.31%)	(36.74%)	(34.25%)
ROIC Full definition →		(158.98%)	(153.90%)	(141.03%)	(129.86%)
Return on Tangible Assets Full definition →		(64.41%)	(70.10%)	(69.12%)	(65.38%)
Average Days of Receivables Full definition →		48.69	44.64	51.12	49.40
Free Cash Flow per Share Full definition →		(0.81)	(0.70)	(0.72)	(0.59)
Free Cash Flow Full definition →		(32.83)	(29.41)	(30.67)	(25.61)
Capital Expenditures Full definition →		(0.45)	(0.16)	(0.11)	(0.03)
Other line items
Cash ROIC Full definition →		(20.38%)	(20.31%)	(23.11%)	(20.51%)
Accounts Receivable Turnover Full definition →		7.18	7.14	6.21	6.88
Accounts Payable Turnover Full definition →		6.04	5.60	3.57	3.67
Inventory Turnover Full definition →		1.43	1.31	1.23	1.27
Average Days of Payables Full definition →		61.02	58.42	85.05	82.14
Days of Inventory on Hand Full definition →		247.60	274.29	298.18	281.02
Tax Rate Full definition →		0.01	0.01	0.01	0.01
Research and Development Expense of Revenue Full definition →		21.54%	22.17%	22.14%	21.83%
Selling, General and Administrative Expense of Revenue Full definition →		111.95%	112.10%	107.87%	99.97%
Share Based Compensation of Revenue Full definition →		23.46%	22.31%	19.72%	17.67%
Interest Coverage Full definition →		(17.01)	(15.54)	(12.29)	(9.39)
Operating CF/Net income Full definition →		0.60	0.55	0.64	0.60
Depreciation/Fixed assets Full definition →		0.33	0.44	0.57	0.68
Capex/Depreciation Full definition →		(0.62)	(0.18)	(0.10)	(0.03)
Revenue per Share Full definition →		2.22	2.11	2.06	2.06
Operating CF per Share Full definition →		(0.80)	(0.70)	(0.72)	(0.59)
Capex per Share Full definition →		(0.01)	0.00	0.00	0.00
Capex to Sales Full definition →		0.01	0.00	0.00	0.00

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly